Vertex could be close to a price deal with the NHS over its portfolio of cystic fibrosis drugs, after health ministers wrote to the US firm asking for a conclusion to talks after almost two years ...

NHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio, just days after the EMA’s human medicines committee recommended approval of the drug.

Learn about cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs, and how to treat and live with this chronic disease. 12 min read What Is Cystic Fibrosis? Cystic ...

RTE Room to Improve viewers were moved to tears tonight as an old home was transformed into something “amazing” for Cystic ...

Big Issues Changemakers in health and disability are working to improve the lives of those marginalised by society.

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

Truist Financial analyst Joon Lee maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today. The company’s shares closed ...

In a report released today, Greg Harrison from Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...

It was an everyday situation that became a nightmare no parent should have to face. Two-year-old Ava Hodgkinson was under the ...

The major work programmes mapped out in this Plan are underpinned by an agreed, costed and phased NHS technology plan, ...

A BBC Morning Live doctor has said that whilst mould may look unsightly, it could be causing more issues than just making ...

Home NHS Five Year Forward View Next steps on the NHS Five Year Forward View ...